Since the onset of the COVID-19 pandemic, significant progress has been made in
developing effective preventive and therapeutic strategies against severe acute SARS-CoV …

Introduction More than 3 years into the pandemic, there is persisting uncertainty as to the
etiology, biomarkers, and risk factors of Post COVID-19 Condition (PCC). Serological …

As we are moving into the Flu season, a raise in infection with a new variant of SARS-CoV-2
is noted. The Food and Drug Administration and the Centers for Disease Control (CDC) …

The impact of pre-existing neutralizing antibodies (NAbs) titers on SARS-CoV-2 viral
shedding dynamics in post-vaccination infection (PVI) are not well understood. We …

The rapid spread of SARS-CoV2 and continuing impact on human health has prompted the
need for effective and rapid development of monoclonal antibody therapeutics. In this study …

Introduction More than three years into the pandemic, there is persisting uncertainty as to the
etiology, biomarkers, and risk factors of Post COVID-19 Condition (PCC). Serological …